M&A/ News/ News/ News/ Oncology/ R&D/ R&D/ Top stories

Novo Nordisk and Celgene lead January pharma M&A

Richard Staines blood cancer, Celgene, Haematology, Impact Biomedicines, M&A, Mergers and acquisitions, Novo Nordisk 0 Comment